president, chief executive officer and director at InCarda Therapeutics - Newark, CA, US
InCarda Therapeutics is an early-stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF).